Zhixue Bao Pian (止血宝片)止血宝片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

小蓟是一种在国家药监局注册认定的药品。该药品含有小蓟-b8ae7d71等成分。

该药品关联的活性成分包括:小蓟Xiao Ji。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:海南全星制药有限公司Chinese legal name: 海南全星制药有限公司。

您可以探索含有相同成分的其他药品:小蓟-b8ae7d71成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 止血宝片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 小蓟Xiao Ji.

Manufacturers recorded for this product: 海南全星制药有限公司Chinese legal name: 海南全星制药有限公司.

Explore other medicines containing the same ingredient: 小蓟 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 止血宝片Recorded Chinese name: 止血宝片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 每片重0.3g0.3 g per tablet

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 海南全星制药有限公司Chinese legal name: 海南全星制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z46020094

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z46020094

Manufacturer

Chinese legal name: 海南全星制药有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z46020094

生产企业

海南全星制药有限公司(国产)

功能主治

凉血止血,祛瘀消肿。用于鼻出血、吐血、尿血、便血、崩漏下血。

用法用量

口服。一次2~4片,一日2~3次。

不良反应

尚不明确。

禁忌

1.孕妇禁用。
2.对本品及其成分过敏者禁用。
3.合并有心脑血管、肝、肾和造血系统等严重原发性疾病者禁用。

注意事项

1.阴虚火旺证临床表现为潮热盗汗、手脚心热、两颧潮红等的出血患者慎用。
2.如果患有可能引起出血的其他疾病,请针对原发疾病进行相应处理。
3.出血量大时,要考虑采用局部止血快速止血。鼻衄病人采用直坐位,或抬高头部,用冷水敷额头、颈部,或用手指紧压两侧鼻翼;咯血量多者绝对卧床,取卧位或侧卧位,患者轻咳嗽,勿屏气,必须将血咯出;吐血量大者,应保持头低脚高侧卧位,避免血液流入气道引起窒息,同时应暂时禁食。
4.出血量多难止,病人面色苍白,血压下降者,需作紧急救治。
5.服药期间,不要饮酒,吸烟。饮食宜清淡,避免辛辣香燥之品。
6.患者宜保持情绪平稳,避免急躁动怒。
7.服药期间,注意休息,避免劳累,保证充足的睡眠。

贮藏

密封,防潮。

规格

每片重0.3g

证据Evidence

  • 批准文号: 国药准字Z46020094
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.